Answers are grounded in this paper and cite their sources.
A small proportion of Escherichia coli and Klebsiella pneumoniae demonstrate in vitro non-susceptibility to piperacillin/tazobactam but retain susceptibility to ceftriaxone. Uncertainty remains regarding how best to treat these isolates.
No takes yet. Share an insight, caveat, or question.
Mourad et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: